Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic platform that can help close vaccination gaps and quickly detect ...

BOSTON--(BUSINESS WIRE)--Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...

Febit, a developer of automated solutions for enabling biochip applications, has integrated components of the InforSense platform to provide data analysis and visualization in the developer's Geniom ...

NEW YORK, NY, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Panther Life Sciences announces expanded access to its high-precision Microarray Patch (MAP ...

Microarray technology has come of age as a powerful approach to revealing the genome and its dynamic expression through the application of gene-hybridization or gene-expression microarrays. While the ...

*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...

The ability to quantitatively probe diverse panels of proteins and their post-translational modifications (PTMs) across multiple samples would aid a broad spectrum of biological, biochemical, and ...

Disparities between microarray data from different groups working on similar samples has made many question the validity of this widely adopted technology. Although the 'minimal information about a ...

The formal reports of the work conducted by the MicroArray Quality Control (MAQC) consortium lay the groundwork for microarrays to gain acceptance as a clinical diagnostic and drug development tool.

XenoSarc: A comprehensive platform of patient-derived xenograft (PDX) models of soft tissue sarcoma (STS) for early drug testing. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...